ICGC
Data Portal
Get Cancer Data
Data Access Compliance Office
Apply for Access to Controlled Data
Contact Us

Login | Create an ICGC account

International Cancer Genome Consortium

Search this site:

Home
Cancer Genome Projects
Committees and Working Groups
Policies and Guidelines
Media

ICGC ›

Tumor Type

Bladder and Urinary Tract (1)
- Bladder Cancer - Invasive Urothelial Bladder Cancer
Bone (1)
- Bone Cancer - Osteosarcoma / chondrosarcoma / rare subtypes
Breast (5)
- Breast Cancer - ER+ve, HER2-ve
- Breast Cancer - Subtype defined by an amplification of the HER2 gene
- Breast Cancer - Triple Negative/lobular/other
- Breast Cancer - Ductal & lobular
- Breast Cancer - Ductal carcinoma
Central Nervous System (4)
- Pediatric Brain Tumors - Medulloblasma & Pediatric Pilocytic Astrocytoma
- Brain Cancer - Glioblastoma multiforme
- Brain Cancer - Pediatric Medulloblastoma
- Brain Cancer - Lower grade glioma
Cervix (1)
- Cervical Cancer - Cervical squamous cell carcinoma
Colorectal (1)
- Colorectal Cancer - Adenocarcinoma
Endocrine Tissues (0)
Esophagus (1)
- Esophageal Cancer - Esophageal adenocarcinoma
Gall Bladder and Biliary System (0)
Head, Neck and Nasopharynx (4)
- Oral Cancer - Gingivobuccal
- Head and Neck Cancer - Squamous cell carcinoma
- Head and Neck Cancer - Squamous cell carcinoma of oral cavity / oropharynx / sinonasal cavity / hypopharynx / larynx
- Head and Neck Cancer - Thyroid carcinoma
Hematopoietic and Lymphoid Tissues (5)
- Chronic Lymphocytic Leukemia - CLL with mutated and unmutated IgVH
- Blood Cancer - Acute Myeloid Leukemia
- Malignant Lymphoma - Germinal center B-cell derived lymphomas
- Chronic Myeloid Disorders - Myelodysplastic Syndromes, Myeloproliferative Neoplasms & Other Chronic Myeloid Malignancies
- Non Hodgkin Lymphoma - Diffuse large B cell lymphoma
Kidney (3)
- Renal Cancer - Renal cell carcinoma (Focus on but not limited to clear cell subtype)
- Renal Cancer - Clear cell carcinoma
- Renal Cancer - Papillary carcinoma
Liver (3)
- Liver Cancer - Hepatocellular carcinoma (Secondary to alcohol and adiposity)
- Liver Cancer - Hepatocellular carcinoma (Virus associated)
- Liver Cancer - Hepatocellular carcinoma
Lung (2)
- Lung Cancer - Adenocarcinoma
- Lung Cancer - Squamous cell carcinoma
Ovary (2)
- Ovarian Cancer - Serous cystadenocarcinoma
- Ovarian Cancer - Serous cystadenocarcinoma
Pancreas (4)
- Pancreatic Cancer - Ductal adenocarcinoma
- Pancreatic Cancer - Ductal adenocarcinoma
- Rare Pancreatic Tumors - Enteropancreatic endocrine tumors and rare pancreatic exocrine tumors
- Pancreatic Cancer - Adenocarcinoma
Skin (1)
- Skin Cancer - Cutaneous melanoma
Soft Tissue (0)
Stomach (2)
- Gastric Cancer - Intestinal- and diffuse-type
- Gastric Cancer - Adenocarcinoma
Testis and Prostate (4)
- Prostate Cancer - Early Onset
- Prostate Cancer - Adenocarcinoma
- Prostate Cancer - Adenocarcinoma
- Prostate Cancer - Adenocarcinoma
Uterus (1)
- Endometrial Cancer - Uterine corpus endometrial carcinoma

Tumor Type

Bladder and Urinary Tract (1)
- Bladder Cancer - Invasive Urothelial Bladder Cancer
Bone (1)
- Bone Cancer - Osteosarcoma / chondrosarcoma / rare subtypes
Breast (5)
- Breast Cancer - ER+ve, HER2-ve
- Breast Cancer - Subtype defined by an amplification of the HER2 gene
- Breast Cancer - Triple Negative/lobular/other
- Breast Cancer - Ductal & lobular
- Breast Cancer - Ductal carcinoma
Central Nervous System (4)
- Pediatric Brain Tumors - Medulloblasma & Pediatric Pilocytic Astrocytoma
- Brain Cancer - Glioblastoma multiforme
- Brain Cancer - Pediatric Medulloblastoma
- Brain Cancer - Lower grade glioma
Cervix (1)
- Cervical Cancer - Cervical squamous cell carcinoma
Colorectal (1)
- Colorectal Cancer - Adenocarcinoma
Endocrine Tissues (0)
Esophagus (1)
- Esophageal Cancer - Esophageal adenocarcinoma
Gall Bladder and Biliary System (0)
Head, Neck and Nasopharynx (4)
- Oral Cancer - Gingivobuccal
- Head and Neck Cancer - Squamous cell carcinoma
- Head and Neck Cancer - Squamous cell carcinoma of oral cavity / oropharynx / sinonasal cavity / hypopharynx / larynx
- Head and Neck Cancer - Thyroid carcinoma
Hematopoietic and Lymphoid Tissues (5)
- Chronic Lymphocytic Leukemia - CLL with mutated and unmutated IgVH
- Blood Cancer - Acute Myeloid Leukemia
- Malignant Lymphoma - Germinal center B-cell derived lymphomas
- Chronic Myeloid Disorders - Myelodysplastic Syndromes, Myeloproliferative Neoplasms & Other Chronic Myeloid Malignancies
- Non Hodgkin Lymphoma - Diffuse large B cell lymphoma
Kidney (3)
- Renal Cancer - Renal cell carcinoma (Focus on but not limited to clear cell subtype)
- Renal Cancer - Clear cell carcinoma
- Renal Cancer - Papillary carcinoma
Liver (3)
- Liver Cancer - Hepatocellular carcinoma (Secondary to alcohol and adiposity)
- Liver Cancer - Hepatocellular carcinoma (Virus associated)
- Liver Cancer - Hepatocellular carcinoma
Lung (2)
- Lung Cancer - Adenocarcinoma
- Lung Cancer - Squamous cell carcinoma
Ovary (2)
- Ovarian Cancer - Serous cystadenocarcinoma
- Ovarian Cancer - Serous cystadenocarcinoma
Pancreas (4)
- Pancreatic Cancer - Ductal adenocarcinoma
- Pancreatic Cancer - Ductal adenocarcinoma
- Rare Pancreatic Tumors - Enteropancreatic endocrine tumors and rare pancreatic exocrine tumors
- Pancreatic Cancer - Adenocarcinoma
Skin (1)
- Skin Cancer - Cutaneous melanoma
Soft Tissue (0)
Stomach (2)
- Gastric Cancer - Intestinal- and diffuse-type
- Gastric Cancer - Adenocarcinoma
Testis and Prostate (4)
- Prostate Cancer - Early Onset
- Prostate Cancer - Adenocarcinoma
- Prostate Cancer - Adenocarcinoma
- Prostate Cancer - Adenocarcinoma
Uterus (1)
- Endometrial Cancer - Uterine corpus endometrial carcinoma

Please select a Cancer Genome Project

Choose from either Tumor Type or Lead Jurisdiction

Lead Jurisdiction

Australia (2)
- Ovarian Cancer - Serous cystadenocarcinoma
- Pancreatic Cancer - Ductal adenocarcinoma
Canada (3)
China (1)
- Gastric Cancer - Intestinal- and diffuse-type
European Union / France (1)
- Renal Cancer - Renal cell carcinoma (Focus on but not limited to clear cell subtype)
European Union / United Kingdom (1)
- Breast Cancer - ER+ve, HER2-ve
France (2)
- Breast Cancer - Subtype defined by an amplification of the HER2 gene
- Liver Cancer - Hepatocellular carcinoma (Secondary to alcohol and adiposity)
Germany (3)
India (1)
- Oral Cancer - Gingivobuccal
Italy (1)
- Rare Pancreatic Tumors - Enteropancreatic endocrine tumors and rare pancreatic exocrine tumors
Japan (1)
- Liver Cancer - Hepatocellular carcinoma (Virus associated)
Mexico (3)
Spain (1)
- Chronic Lymphocytic Leukemia - CLL with mutated and unmutated IgVH
United Kingdom (5)
United States (20)

Lead Jurisdiction

Australia (2)
- Ovarian Cancer - Serous cystadenocarcinoma
- Pancreatic Cancer - Ductal adenocarcinoma
Canada (3)
China (1)
- Gastric Cancer - Intestinal- and diffuse-type
European Union / France (1)
- Renal Cancer - Renal cell carcinoma (Focus on but not limited to clear cell subtype)
European Union / United Kingdom (1)
- Breast Cancer - ER+ve, HER2-ve
France (2)
- Breast Cancer - Subtype defined by an amplification of the HER2 gene
- Liver Cancer - Hepatocellular carcinoma (Secondary to alcohol and adiposity)
Germany (3)
India (1)
- Oral Cancer - Gingivobuccal
Italy (1)
- Rare Pancreatic Tumors - Enteropancreatic endocrine tumors and rare pancreatic exocrine tumors
Japan (1)
- Liver Cancer - Hepatocellular carcinoma (Virus associated)
Mexico (3)
Spain (1)
- Chronic Lymphocytic Leukemia - CLL with mutated and unmutated IgVH
United Kingdom (5)
United States (20)

International Cancer Genome Consortium (ICGC)
ICGC Data Portal (DCC)
Data Access Compliance Office (DACO)
Contact Us
- Online Form
- Terms & Conditions | Privacy Policy
- © 2011 International Cancer Genome Consortium. All rights reserved.
© 2011 International Cancer Genome Consortium. All rights reserved.